All Topics
All Topics
Technology
Technology
AI
AI
Business
Business
Entertainment
Entertainment
News
News
Programming
Programming
Science
Science
Design
Design
Environment
Environment
Finance
Finance
Crypto
Crypto
Politics
Politics
Sports
Sports
Education
Education
Gaming
Gaming
Art
Art
Music
Music
Health
Health
Security
Security
Books
Books
Food
Food
Travel
Travel
Personal
Personal
Bluesky
Twitter

Indian Pharmacopoeia Commission signs MoU with UP Promote Pharma Council

Read the full article
en

You might also wanna read

Indian Pharmacopoeia Commission signs MoU with UP Promote Pharma Council to strengthen quality, innovation, and regulatory excellence in healthcare

New Delhi [India], July 15 (ANI): In a major step towards advancing high-quality healthcare standards and strengthening the regulatory frame

bignewsnetwork.com·1d ago

IPC signs MoU with UP Promote Pharma Council to strengthen quality standards

The MoU comes as Uttar Pradesh seeks to expand investments in pharmaceuticals and medical technology through industrial clusters and manufac

thehindubusinessline.com·1d ago

SAI, Safdarjung SIC sign MoU to boost sports science, medicine

The Sports Authority of India and the Safdarjung Sports Injury Centre signed an MoU to enhance sports science, medicine, and athlete rehabil

Asianet Newsable·8d ago

Emirates Dermatology Society and LEO Pharma sign MoU to advance Chronic Hand Eczema awareness in UAE

The agreement was signed alongside the opening of LEO Pharma’s new office in Expo City Dubai, which marks a milestone in the company’s regio

Zawya·10d ago

University of Doha for Science and Technology signs MoU with Qatar Armed Forces Medical Services

Reinforcing cooperation in education, training, research, and knowledge exchange

Zawya·11d ago

SAI and Safdarjung Sports Injury Centre sign MoU to strengthen sports science and athlete care

New Delhi [India], July 9 (ANI): The Sports Authority of India (SAI), under the Ministry of Youth Affairs & Sports (MYAS), and the Safdarjun

bignewsnetwork.com·7d ago

Comments

Sign in to join the conversation.

No comments yet. Be the first.